Premium
Post‐transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high‐risk acute myeloid leukaemia
Author(s) -
Oshikawa Gaku,
Kakihana Kazuhiko,
Saito Makoto,
Aoki Jun,
Najima Yuho,
Kobayashi Takeshi,
Doki Noriko,
Sakamaki Hisashi,
Ohashi Kazuteru
Publication year - 2015
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13248
Subject(s) - gemtuzumab ozogamicin , azacitidine , myeloid leukaemia , medicine , calicheamicin , maintenance therapy , oncology , myeloid leukemia , stem cell , chemotherapy , cd33 , cd34 , biochemistry , gene expression , genetics , chemistry , gene , dna methylation , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom